dihexa clinical trial human studies trials Dihexa dihexa human trials status 2026
Description
Append it only to the E/M code
A natural compound with analgesic and neuroprotective properties (though primarily in the central nervous system) is HCIQ2c1, a peptide isolated from the sea anemone Heteractis magnifica , classified as a Kunitz-type serine protease inhibitor [204]
The results show that the rs1941404 variation is significantly associated with T2D [34]
Serious adverse effects have not been widely reported, but long-term safety data in humans is lacking
